Professor, Internal Medicine, University of Iowa College of Medicine
Hematology
Dr. Donald E. MacFarlane, MD
|
|
Give Review
Donald MacFarlane is an expert in the field of Hematology. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Donald E. MacFarlane, MD is a published doctor and has 17 publications published. The lastest was: 'Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.' He accepts Medicare.
Publications
- Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
- Synthesis and activity of substituted 2-phenylquinolin-4-amines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
- Chloroquine prevention of murine MHC-disparate Acute graft-versus-host disease correlates with inhibition of splenic response to CpG oligodeoxynucleotides and alterati...
- Acute graft-versus-host disease resulting from normal donor blood transfusions.
- Protein kinase C is not necessary for transforming growth factor beta-induced growth-arrest in Leukemia cell lines.
- Activation of beta-isozyme of protein kinase C (PKC beta) is necessary and sufficient for phorbol ester-induced differentiation of HL-60 promyelocytes. Studies with PK...
- CpG-oligodeoxynucleotide-resistant variant of WEHI 231 Cells.
- Immunostimulatory CpG-oligodeoxynucleotides induce a factor that inhibits macrophage adhesion.
- Lack of Immune stimulation by immobilized CpG-oligodeoxynucleotide.
- CpG-oligodeoxynucleotide supports growth of IL-6-dependent 7TD1 murine hybridoma Cells.
- Unmethylated CpG-containing oligodeoxynucleotides inhibit apoptosis in WEHI 231 B lymphocytes induced by seVeral agents: evidence for blockade of apoptosis at a distal...
- Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds.
- Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: mechanistic studies.
- Structure-activity relationship analysis of substituted 4-quinolinamines, antagonists of immunostimulatory CpG-oligodeoxynucleotides.
- Bis-4-aminoquinolines: novel triple-helix DNA intercalators and antagonists of immunostimulatory CpG-oligodeoxynucleotides.
- Fujita-Ban QSAR analysis and CoMFA study of quinoline antagonists of immunostimulatory CpG-oligodeoxynucleotides.
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Burkitt's Lymphoma
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Iowa Hospitals and Clinics
Drug Facts
| NPI NUMBER | 1013905181 | |
| NPPES Provider LastName | MACFARLANE | |
| NPPES Provider FirstName | DONALD | |
| NPPES Provider ZIPCode | 522421009 | |
| NPPES Provider State | IA | |
| Specialty Description | Hematology | |
| Total Claim Count | 449.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 53.0 | |
| Percent Opioid Claims | 11.8 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1013905181 |
| Last Name Of The Provider | MACFARLANE |
| First Name Of The Provider | DONALD |
| View All |
Similar Doctors
|
|
Dr. Eric S. Engelman, DO |
|
|
Dr. Steven R. Lentz, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ahmad M. Wehbe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George J. Weiner, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Umar Farooq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evelena Ontiveros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark W. Karwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michel R. Nasr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Guido Tricot, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wenshuo Shao, MD |
|
|
Dr. Nitin J. Karandikar, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Grerk Sutamewagul, MD |